Results 21 to 30 of about 5,247 (197)

Methods for the preparation of lysophosphatidylcholine

open access: yesJournal of Pharmacy and Pharmacology, 1971
Abstract The surfactant and solubilizing properties of lysophosphatidylcholine (LPC) could have industrial uses if it became available in technical quantity and purity. The two most promising routes for obtaining it are isolation from cereal starches and mono-deacylation of egg phosphatidylcholine (PC). Baker's yeast autolysed by Letters'
D S, Merryfield, J J, Wren
openaire   +2 more sources

Continuous fluorescence assay for lecithin:cholesterol acyltransferase using a water-soluble phosphatidylcholine.

open access: yesJournal of Lipid Research, 1992
A water-soluble fluorescent phosphatidylcholine, 1,2-bis[4-(1-pyreno-butanoyl]-sn-glycero-3-phosphocholine (DPybPC) has been used to develop a sensitive, continuous assay for pure lecithin:cholesterol acyltransferase (LCAT) in solution.
FS Bonelli, A Jonas
doaj   +1 more source

ATP Release Drives Inflammation with Lysophosphatidylcholine [PDF]

open access: yesImmunoHorizons, 2020
Abstract Lysophosphatidylcholine (LPC), a dominant lipid component of oxidized low-density lipoprotein, plays a major role in inflammation associated with atherosclerosis and neurodegenerative disorders. It activates inflammatory responses from macrophages, neuronal cells, and endothelial cells.
Sana, Ismaeel, Ayub, Qadri
openaire   +3 more sources

The presence of lysophosphatidylcholine in chromaffin granules [PDF]

open access: yesBiochemical Journal, 1980
Lysophosphatidylcholine is thought to be a characteristic component of the chromaffin granules in adrenal glands. By the use of a t.l.c. system that resolves minor phospholipids satisfactorily, this subcellular location was confirmed in the present study in bovine glands.
G, Arthur, A, Sheltawy
openaire   +2 more sources

Metabolomics reveals LysoPC a C17:0 (LPC 17:0) as candidate biomarker for personalized medicine in morbid obesity

open access: yesFrontiers in Medicine
Morbid obesity represents the most severe form of obesity and is associated with increased cardiometabolic risk, including type 2 diabetes and cardiovascular complications. Current diagnostic approaches rely on anthropometric measures, failing to capture
Eleonora Stefanini   +18 more
doaj   +1 more source

Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties

open access: yesJournal of Inflammation, 2008
Background Lysophosphatidylcholines (lysoPCs) are products of phospholipase A2 (PLA2) enzyme activity, and like the enzyme, have a direct role in toxic inflammatory responses in variety of organ systems.
Lucena Angel   +2 more
doaj   +1 more source

Defining Acute Coronary Syndrome through Metabolomics

open access: yesMetabolites, 2021
As an emerging platform technology, metabolomics offers new insights into the pathomechanisms associated with complex disease conditions, including cardiovascular diseases.
Arun Surendran   +4 more
doaj   +1 more source

Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes [PDF]

open access: yesJournal of Lipid Research, 2008
The pathogenesis of nonalcoholic steatohepatitis (NASH) is unclear, despite epidemiological data implicating FFAs. We studied the pathogenesis of NASH using lipoapoptosis models. Palmitic acid (PA) induced classical apoptosis of hepatocytes. PA-induced lipoapoptosis was inhibited by acyl-CoA synthetase inhibitor but not by ceramide synthesis inhibitors,
Myoung Sook Han   +15 more
openaire   +4 more sources

Lipoprotein-associated phospholipase А2 as a biomarker and potential therapeutic target in post-stroke cognitive impairment

open access: yesАнналы клинической и экспериментальной неврологии
Post-stroke cognitive impairment (PSCI) is a major complication of cerebrovascular disease, spanning from mild cognitive impairment to dementia. PSCI pathogenesis involves complex mechanisms, including neuroinflammation, oxidative stress, and neuronal ...
Chandra Wirawan   +5 more
doaj   +1 more source

Action mechanism of hypoglycemic principle 9-(R)-HODE isolated from cortex lycii based on a metabolomics approach

open access: yesFrontiers in Pharmacology, 2022
The 9-(R)-HODE is an active compound isolated from cortex lycii that showed significant hypoglycemic effects in our previous in vitro study. In this study, 9-(R)-HODE’s in vivo hypoglycemic activity and effect on alleviating diabetic complications ...
Yueqiu Liu   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy